PEP079
Invitrogen™ Human EEA1 (aa 1391-1410) Synthetic Peptide
Manufacturer: Invitrogen™
The price for this product is unavailable. Please request a quote
Gene ID (Entrez)
8411
Purification Method
purified
Common Name
Human EEA1 (aa 1391-1410)
Content And Storage
-20°C. Avoid freeze-thaw cycles.
Format
Lyophilized
For Use With (Application)
Control
Lyophilized
Yes
Product Type
Peptide
Regulatory Status
RUO - research use only
Species
Human
Accession Number
Q15075
Concentration
0.5 mg/mL
Description
Synthetic Peptide
Formulation
peptide with no preservative
Gene Symbol
EEA1
Preservative
No preservative
Quantity
50 μg
Sequence
T(1391) - P- S- S- K- K- P- V- R- V- C- D- A- C- F- N- D- L - Q- G(1410)
Related Products
Description
- Human EEA1 (residues 1391-1410) Synthetic Peptide, PEP-079, from Invitrogen
- PEP-079 is a 21 amino acid synthetic peptide whose sequence corresponds to amino acids 1391-1410 of the human EEA 1 protein
- The sequence of this peptide is (amino to carboxy terminus): T (1391)-P- S- S- K- K- P- V- R- V- C- D- A- C- F- N- D- L-Q- G (1410)This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human EEA 1, catalog # PA1-063A
- Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (∼70-fold) for competitive inhibition of antibody-protein binding reactions.Reconstitute with 0.1 ml of distilled water.
Compare Similar Items
Show Difference
Gene ID (Entrez): 8411
Purification Method: purified
Common Name: Human EEA1 (aa 1391-1410)
Content And Storage: -20°C. Avoid freeze-thaw cycles.
Format: Lyophilized
For Use With (Application): Control
Lyophilized: Yes
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: Q15075
Concentration: 0.5 mg/mL
Description: Synthetic Peptide
Formulation: peptide with no preservative
Gene Symbol: EEA1
Preservative: No preservative
Quantity: 50 μg
Sequence: T(1391) - P- S- S- K- K- P- V- R- V- C- D- A- C- F- N- D- L - Q- G(1410)
Gene ID (Entrez):
8411
Purification Method:
purified
Common Name:
Human EEA1 (aa 1391-1410)
Content And Storage:
-20°C. Avoid freeze-thaw cycles.
Format:
Lyophilized
For Use With (Application):
Control
Lyophilized:
Yes
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
Q15075
Concentration:
0.5 mg/mL
Description:
Synthetic Peptide
Formulation:
peptide with no preservative
Gene Symbol:
EEA1
Preservative:
No preservative
Quantity:
50 μg
Sequence:
T(1391) - P- S- S- K- K- P- V- R- V- C- D- A- C- F- N- D- L - Q- G(1410)
Gene ID (Entrez): 387882
Purification Method: purified
Common Name: Human OCC1
Content And Storage: -20°C
Format: Liquid
For Use With (Application): Blocking Assay, Control
Lyophilized: No
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: Q8TAD7
Concentration: 200 μg/mL
Description: Synthetic Peptide
Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol: C12orf75
Preservative: 0.02% sodium azide
Quantity: 50 μg
Sequence: __
Gene ID (Entrez):
387882
Purification Method:
purified
Common Name:
Human OCC1
Content And Storage:
-20°C
Format:
Liquid
For Use With (Application):
Blocking Assay, Control
Lyophilized:
No
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
Q8TAD7
Concentration:
200 μg/mL
Description:
Synthetic Peptide
Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol:
C12orf75
Preservative:
0.02% sodium azide
Quantity:
50 μg
Sequence:
__
Gene ID (Entrez): 10748
Purification Method: purified
Common Name: Human KLRA1
Content And Storage: -20°C
Format: Liquid
For Use With (Application): Blocking Assay, Control
Lyophilized: No
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: __
Concentration: 200 μg/mL
Description: Synthetic Peptide
Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol: KLRA1P
Preservative: 0.02% sodium azide
Quantity: 50 μg
Sequence: __
Gene ID (Entrez):
10748
Purification Method:
purified
Common Name:
Human KLRA1
Content And Storage:
-20°C
Format:
Liquid
For Use With (Application):
Blocking Assay, Control
Lyophilized:
No
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
__
Concentration:
200 μg/mL
Description:
Synthetic Peptide
Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol:
KLRA1P
Preservative:
0.02% sodium azide
Quantity:
50 μg
Sequence:
__
Gene ID (Entrez): 10748
Purification Method: purified
Common Name: Human KLRA1
Content And Storage: -20°C
Format: Liquid
For Use With (Application): Blocking Assay, Control
Lyophilized: No
Product Type: Peptide
Regulatory Status: RUO - research use only
Species: Human
Accession Number: __
Concentration: 200 μg/mL
Description: Synthetic Peptide
Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol: KLRA1P
Preservative: 0.02% sodium azide
Quantity: 50 μg
Sequence: __
Gene ID (Entrez):
10748
Purification Method:
purified
Common Name:
Human KLRA1
Content And Storage:
-20°C
Format:
Liquid
For Use With (Application):
Blocking Assay, Control
Lyophilized:
No
Product Type:
Peptide
Regulatory Status:
RUO - research use only
Species:
Human
Accession Number:
__
Concentration:
200 μg/mL
Description:
Synthetic Peptide
Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Symbol:
KLRA1P
Preservative:
0.02% sodium azide
Quantity:
50 μg
Sequence:
__